Maze Therapeutics Inc. (MAZE)
Market Closed
3 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
25. 87
-0.85
-3.1811%
$
1.52B Market Cap
- P/E Ratio
- Div Yield
477,427 Volume
- Eps
$ 26.72
Previous Close 
Want to track MAZE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Maze Therapeutics Inc. (MAZE) Statistics
Valuation metrics
Market Cap 1.52B
Enterprise value 1.38B
Trailing P/E (ttm) -10.01
Forward P/E -
PEG ratio 0.19
Price/Sales (ttm) 75.93
Price/Book (mrq) 3.57
Enterprise Value/Revenue 68.82
Enterprise Value/EBITDA -10.57
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 250.05K
Average volume (90 days) 712.37K
Price summary
52-Week low 14.16
52-Week high 53.65
Beta -
50-Day moving average 27.59
200-Day moving average 34.18
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.68%
Operating margin -7.28%
Operational effectiveness
Return on assets -0.25%
Return on equity -0.35%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.34
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.97
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 18.31%
Book value per share (mrq) 7.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
